Price Alert

GeneDx Corp. (WGS)

NASDAQ: WGS · Real-Time Price · USD

126.31

3.43 (2.79%)

At close: Aug 15, 2025, 3:59 PM

125.51

-0.63%

After-hours: Aug 15, 2025, 05:40 PM EDT

GeneDx Statistics

Share Statistics

GeneDx has 28.73M shares outstanding. The number of shares has increased by 5.93% in one year.

Shares Outstanding	28.73M
Shares Change (YoY)	5.93%
Shares Change (QoQ)	1.66%
Owned by Institutions (%)	99.99%
Shares Floating	25.05M
Failed to Deliver (FTD) Shares	160
FTD / Avg. Volume	0.02%

Short Selling Information

The latest short interest is 3.48M, so 12.2% of the outstanding shares have been sold short.

Short Interest	3.48M
Short % of Shares Out	12.2%
Short % of Float	30.28%
Short Ratio (days to cover)	4.77

Valuation Ratios

The PE ratio is -39.53 and the forward PE ratio is 44.97. GeneDx's PEG ratio is 0.54.

PE Ratio	-39.53
Forward PE	44.97
PS Ratio	6.77
Forward PS	6.5
PB Ratio	8.43
P/FCF Ratio	-60.81
PEG Ratio	0.54

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for GeneDx.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.47.

Current Ratio	3.61
Quick Ratio	3.42
Debt / Equity	0.47
Debt / EBITDA	-4.2
Debt / FCF	-3.42
Interest Coverage	-7.66

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$305.45K
Profits Per Employee	$-52.29K
Employee Count	1,000
Asset Turnover	0.73
Inventory Turnover	10.43

Taxes

Income Tax	-343K
Effective Tax Rate	0.65%

Stock Price Statistics

The stock price has increased by 230.5% in the last 52 weeks. The beta is 2.08, so GeneDx's price volatility has been higher than the market average.

Beta	2.08
52-Week Price Change	230.5%
50-Day Moving Average	83.32
200-Day Moving Average	81.55
Relative Strength Index (RSI)	68.04
Average Volume (20 Days)	945,687

Income Statement

In the last 12 months, GeneDx had revenue of 305.45M and earned -52.29M in profits. Earnings per share was -1.94.

Revenue	305.45M
Gross Profit	194.4M
Operating Income	-23.21M
Net Income	-52.29M
EBITDA	-27.64M
EBIT	-49.6M
Earnings Per Share (EPS)	-1.94

Full Income Statement

Balance Sheet

The company has 85.21M in cash and 116.17M in debt, giving a net cash position of -30.96M.

Cash & Cash Equivalents	85.21M
Total Debt	116.17M
Net Cash	-30.96M
Retained Earnings	-1.35B
Total Assets	463.86M
Working Capital	133.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.5M and capital expenditures -5.49M, giving a free cash flow of -33.99M.

Operating Cash Flow	-28.5M
Capital Expenditures	-5.49M
Free Cash Flow	-33.99M
FCF Per Share	-1.26

Full Cash Flow Statement

Margins

Gross margin is 63.64%, with operating and profit margins of -7.6% and -17.12%.

Gross Margin	63.64%
Operating Margin	-7.6%
Pretax Margin	-17.23%
Profit Margin	-17.12%
EBITDA Margin	-9.05%
EBIT Margin	-7.6%
FCF Margin	-11.13%

Dividends & Yields

WGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for WGS is $95, which is -14.1% lower than the current price. The consensus rating is "Buy".

Price Target	$95
Price Target Difference	-14.1%
Analyst Consensus	Buy
Analyst Count	9

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 4, 2023. It was a backward split with a ratio of 1:33.

Last Split Date	May 4, 2023
Split Type	backward
Split Ratio	1:33

Scores

Altman Z-Score	6.77
Piotroski F-Score	7